FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291020004> ?p ?o ?g. }

• W4291020004 abstract "ME/CFS is a disorder characterized by recurrent fatigue and intolerance to exertion which manifests as profound post-exertional malaise. Prevalence studies internationally have reported highly variable results due to the 20 + diagnostic criteria. For Australia, the prevalence of ME/CFS based on current case definitions is unknown.To report prevalence of ME/CFS in patients aged ≥ 13 years attending Australian primary care settings for years 2015-2019, and provide context for patterns of primary care attendance by people living with ME/CFS.Conducted in partnership with the Patient Advisory Group, this study adopted a mixed methods approach. De-identified primary care data from the national MedicineInsight program were analyzed. The cohort were regularly attending patients, i.e. 3 visits in the preceding 2 years. Crude prevalence rates were calculated for years 2015-2019, by sex, 10-year age groups, remoteness and socioeconomic status. Rates are presented per 100,000population (95% confidence intervals (CI)). Qualitative data was collected through focus groups and in-depth 1:1 interview.Qualitative evidence identified barriers to reaching diagnosis, and limited interactions with primary care due to a lack of available treatments/interventions, stigma and disbelief in ME/CFS as a condition. In each year of interest, crude prevalence in the primary care setting ranged between 94.9/100,000 (95% CI: 91.5-98.5) and 103.9/100,000 population (95%CI: 100.3-107.7), equating to between 20,140 and 22,050 people living with ME/CFS in Australia in 2020. Higher rates were observed for age groups 50-59 years and 40-49 years. Rates were substantially higher in females (130.0-141.4/100,000) compared to males (50.9-57.5/100,000). In the context of the qualitative evidence, our prevalence rates likely represent an underestimate of the true prevalence of ME/CFS in the Australian primary care setting.ME/CFS affects a substantial number of Australians. Whilst this study provides prevalence estimates for the Australian primary care setting, the qualitative evidence highlights the limitations of these. Future research should focus on using robust case ascertainment criteria in a community setting. Quantification of the burden of disease can be used to inform health policy and planning, for this understudied condition." @default.
• W4291020004 created "2022-08-13" @default.
• W4291020004 creator A5011855804 @default.
• W4291020004 creator A5016312496 @default.
• W4291020004 creator A5022656326 @default.
• W4291020004 creator A5027737817 @default.
• W4291020004 creator A5068876307 @default.
• W4291020004 creator A5069268908 @default.
• W4291020004 creator A5070519777 @default.
• W4291020004 creator A5072178828 @default.
• W4291020004 date "2022-08-09" @default.
• W4291020004 modified "2023-10-05" @default.
• W4291020004 title "Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?" @default.
• W4291020004 cites W1995334573 @default.
• W4291020004 cites W2017492435 @default.
• W4291020004 cites W2033195096 @default.
• W4291020004 cites W2037562783 @default.
• W4291020004 cites W2049978535 @default.
• W4291020004 cites W2064648786 @default.
• W4291020004 cites W2102059582 @default.
• W4291020004 cites W2111371848 @default.
• W4291020004 cites W2127807917 @default.
• W4291020004 cites W2132701056 @default.
• W4291020004 cites W2138664283 @default.
• W4291020004 cites W2155596333 @default.
• W4291020004 cites W2167270466 @default.
• W4291020004 cites W2168833309 @default.
• W4291020004 cites W2264400010 @default.
• W4291020004 cites W2305278139 @default.
• W4291020004 cites W2605754441 @default.
• W4291020004 cites W2903844485 @default.
• W4291020004 cites W2922109336 @default.
• W4291020004 cites W2959873153 @default.
• W4291020004 cites W3004040188 @default.
• W4291020004 cites W3012117897 @default.
• W4291020004 cites W3045864147 @default.
• W4291020004 cites W3160825113 @default.
• W4291020004 cites W3198096075 @default.
• W4291020004 cites W3969464 @default.
• W4291020004 cites W4232238896 @default.
• W4291020004 doi "https://doi.org/10.1186/s12889-022-13929-9" @default.
• W4291020004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35945527" @default.
• W4291020004 hasPublicationYear "2022" @default.
• W4291020004 type Work @default.
• W4291020004 citedByCount "5" @default.
• W4291020004 countsByYear W42910200042023 @default.
• W4291020004 crossrefType "journal-article" @default.
• W4291020004 hasAuthorship W4291020004A5011855804 @default.
• W4291020004 hasAuthorship W4291020004A5016312496 @default.
• W4291020004 hasAuthorship W4291020004A5022656326 @default.
• W4291020004 hasAuthorship W4291020004A5027737817 @default.
• W4291020004 hasAuthorship W4291020004A5068876307 @default.
• W4291020004 hasAuthorship W4291020004A5069268908 @default.
• W4291020004 hasAuthorship W4291020004A5070519777 @default.
• W4291020004 hasAuthorship W4291020004A5072178828 @default.
• W4291020004 hasBestOaLocation W42910200041 @default.
• W4291020004 hasConcept C107130276 @default.
• W4291020004 hasConcept C118552586 @default.
• W4291020004 hasConcept C126322002 @default.
• W4291020004 hasConcept C138816342 @default.
• W4291020004 hasConcept C140556311 @default.
• W4291020004 hasConcept C151730666 @default.
• W4291020004 hasConcept C159110408 @default.
• W4291020004 hasConcept C187212893 @default.
• W4291020004 hasConcept C27415008 @default.
• W4291020004 hasConcept C2779343474 @default.
• W4291020004 hasConcept C2779566273 @default.
• W4291020004 hasConcept C2908647359 @default.
• W4291020004 hasConcept C512399662 @default.
• W4291020004 hasConcept C71924100 @default.
• W4291020004 hasConcept C86803240 @default.
• W4291020004 hasConcept C99454951 @default.
• W4291020004 hasConceptScore W4291020004C107130276 @default.
• W4291020004 hasConceptScore W4291020004C118552586 @default.
• W4291020004 hasConceptScore W4291020004C126322002 @default.
• W4291020004 hasConceptScore W4291020004C138816342 @default.
• W4291020004 hasConceptScore W4291020004C140556311 @default.
• W4291020004 hasConceptScore W4291020004C151730666 @default.
• W4291020004 hasConceptScore W4291020004C159110408 @default.
• W4291020004 hasConceptScore W4291020004C187212893 @default.
• W4291020004 hasConceptScore W4291020004C27415008 @default.
• W4291020004 hasConceptScore W4291020004C2779343474 @default.
• W4291020004 hasConceptScore W4291020004C2779566273 @default.
• W4291020004 hasConceptScore W4291020004C2908647359 @default.
• W4291020004 hasConceptScore W4291020004C512399662 @default.
• W4291020004 hasConceptScore W4291020004C71924100 @default.
• W4291020004 hasConceptScore W4291020004C86803240 @default.
• W4291020004 hasConceptScore W4291020004C99454951 @default.
• W4291020004 hasIssue "1" @default.
• W4291020004 hasLocation W42910200041 @default.
• W4291020004 hasLocation W42910200042 @default.
• W4291020004 hasLocation W42910200043 @default.
• W4291020004 hasLocation W42910200044 @default.
• W4291020004 hasOpenAccess W4291020004 @default.
• W4291020004 hasPrimaryLocation W42910200041 @default.
• W4291020004 hasRelatedWork W2006555490 @default.
• W4291020004 hasRelatedWork W2021420848 @default.
• W4291020004 hasRelatedWork W2101374550 @default.
• W4291020004 hasRelatedWork W2182599876 @default.
• W4291020004 hasRelatedWork W2262389864 @default.

• next